SHINE Medical Technologies broke ground on its 54,000-square-foot corporate headquarters and therapeutics production facility in Janesville, Wis., the company announced recently.

“The best work we do at SHINE is the result of working together, collaborating and sharing expertise and experience,” SHINE CEO Greg Piefer said in a statement. “We are getting back to that model in our new headquarters, which will have ample work and meeting space in addition to fitness and other amenities.”

The therapeutics facility will produce lutetium-177 (Lu-177), and the headquarters will continue to focus on SHINE’s growing workforce.

The building is scheduled to be operational in 2022.